Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dupilumab Phase 3 Asthma Trial in China
CTR20181988Phase 3Completed
- Sponsor
- Sanofi
- Start
- Dec 2018
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of dupilumab in asthma, sponsored by Sanofi. Started Dec 2018; status: completed.
02
Drugs
03
Conditions
asthma
Beyond the preview
Go deeper on CTR20181988.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20181988.